Applicant, as named in the Orange Book

Noven Pharms Inc

Next listed expiry: Xelstrym on 6 Jan 2042. 1 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xelstrym · 4 strengths dextroamphetamine	dextroamphetamine	215401	6 Jan 2042	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Combipatch · 2 strengths estradiol; norethindrone acetate	estradiol; norethindrone acetate	020870	open now	no listed protection
Daytrana · 4 strengths methylphenidate	methylphenidate	021514	open now	no listed protection